Open Orphan sees positive trial on mosquito-borne disesases

Company is developing a vaccine to guard against diseases such as malaria and zika

Mosquitos carry several diseases such as malaria, dengue fever, and zika.

Mosquitos carry several diseases such as malaria, dengue fever, and zika.

A trial by Dublin-listed pharmaceutical services company Open Orphan has ascertained that a vaccine it is developing for mosquito-borne diseases such as zika and malaria is “safe and induces a strong immune response in healthy volunteers”.

Open Orphan, a European-focused, rare and orphan drug consulting services platform, informed the Irish stock market of the results of the randomised, placebo-controlled, double-blind phase one trial on Monday.

Please subscribe or sign in to continue reading.
only €1 first month

Insightful opinion is just a away.